Why the study?
Does indomethacin inhibit platelet aggregation differently in responders versus non-responders among adults with chronic glomerulonephritis?
Does indomethacin inhibit platelet aggregation differently in responders versus non-responders among adults with chronic glomerulonephritis?
The reduction of urinary excretion of F.R. antigen by indomethacin in glomerulonephritis may be related to the inhibition of intrarenal platelet aggregation.
Answers are grounded in this paper and cite their sources.
Indomethacin's differential platelet inhibition in glomerulonephritis responders may relate to reduced F.R. antigen excretion; hypothesis-generating and should not change practice.
Indomethacin given to adults with glomerulonephritis usually reduces their urinary excretion of protein and fibrinogen/fibrin-related (F.R.) antigen. Nevertheless, non-responders exist. Platelet aggregation is significantly more strongly inhibited by indomethacin in good responders than in nonresponders. This supports the hypothesis that the reduction of urinary excretion of F.R. antigen during indomethacin administration is related, at least in part, to inhibition of intrarenal platelet aggregation and of the subsequent fibrin deposition.
No takes yet. Share an insight, caveat, or question.
Gaetano et al. (1974) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: